Oracle (ORCL) PT Raised to $147 at Barclays, 'RPO Strength And Capex Ramp Point To Better Times Ahead'

Barclays analyst Raimo Lenschow raised the price target on Oracle (NYSE: ORCL) to $147.00 (from $140.00) while maintaining a Overweight rating.

The analyst comments "Q3 in itself was a solid quarter for ORCL with slightly better application and infrastructure growth. However, the items investors will more likely focus on are higher Capex this quarter and expected next FY ($2.1bn for Q3 underlying, $10bn for FY25) along with healthy RPO growth as this suggests higher cloud growth ahead."

You May Also Be Interested In

• HDFC Asset Management Co Ltd (HDFCAMC:IN) PT Raised to INR3,250 at JPMorgan
• Regenxbio Inc. (RGNX) PT Raised to $32 at Baird
• Corning (GLW) PT Raised to $205 at Truist Securities